What Is Parallel Import Pharmaceuticals?
Parallel import pharmaceuticals refers to the compliant cross-border supply of medicines that are fully licensed and commercially available in their country of origin, imported into a second market where the same medicine may not be locally registered, may be experiencing a shortage, or may be commercially unavailable through standard supply channels.
Parallel import is commonly used to:
- Address drug shortages where a medicine is temporarily or chronically unavailable in the destination market
- Provide access to medicines pending local regulatory registration
- Improve affordability by sourcing from lower-cost licensed markets
- Supply rare and specialty medicines where local market volumes are insufficient for full manufacturer registration
GNH India holds the necessary IEC export licence, CDSCO approvals, and FDA Maharashtra pharmaceutical supply licence to facilitate parallel imports pharmaceuticals compliantly across 180+ countries. We source exclusively from the originating manufacturer or their authorised supply channel, maintaining full chain-of-custody documentation, batch traceability, and regulatory compliance throughout every parallel import transaction.
When Is Parallel Import Used?
Parallel import pharmaceuticals is an established tool used by pharmaceutical companies, hospital procurement teams, licensed importers, and government health bodies to resolve medicine access challenges in their markets.
- Drug shortages and supply gaps — when a parallel imported medicine is unavailable or back-ordered in the destination country, parallel import from a market with available stock resolves the supply gap quickly and compliantly for institutional and B2B buyers.
- Regulatory delays — when a medicine is approved in its origin country but still undergoing registration in the destination market, parallel import provides a compliant bridging mechanism
- Price access — importing from a licensed market where the medicine is available at a lower price improves patient and institutional affordability
- Rare and specialty medicines — where small patient populations make full local registration commercially unviable, parallel imports pharmaceuticals offers a sustainable B2B supply pathway for hospital formularies and specialist procurement teams.
- Hospital formulary needs — for critical medicines not commercially stocked locally, parallel import enables hospitals to maintain formulary continuity
- Orphan and biosimilar medicines — medicines with limited market registrations are frequently supplied via parallel import from primary approval markets
- Pharmaceutical trading and B2B arbitrage — licensed pharmaceutical trading companies and importers use parallel trade pharmaceuticals as a compliant mechanism to source medicines from lower-cost licensed markets for legitimate resale and institutional supply in higher-cost destination markets.
Our Parallel Import Process
GNH India manages every stage of the parallel import process, from initial regulatory assessment to final delivery, ensuring full compliance at every step.
Eligibility Assessment:
We verify that the medicine is fully licensed in its country of origin and determine the applicable regulatory import pathway in the destination country, including any permits, licences, or health authority notifications required.
Regulatory Documentation:
Our regulatory team prepares all required documentation including import permits, certificates of origin, free sale certificates (FSC), manufacturer authorisation letters, and country-specific health authority submissions.
Manufacturer Authorisation:
We secure supply directly from the originating manufacturer or their authorised distributor, with full batch traceability, certificate of analysis, and chain-of-custody documentation. No grey-market or unverified sources are used.
Customs & Compliance Clearance:
Our logistics and compliance teams manage all import declarations, customs classification, excise documentation, and local regulatory compliance. Where required, we coordinate relabelling or language-specific packaging under regulatory oversight.
Secure Delivery:
GDP-compliant delivery to the hospital pharmacy, licensed distributor, or designated healthcare facility, with full temperature control for cold-chain products and real-time shipment tracking throughout transit.
Why Choose GNH India for Parallel Import?
- Licensed pharmaceutical importer with IEC, CDSCO, and FDA Maharashtra approvals for cross-border medicine supply.
- 20+ years of international pharmaceutical supply experience across regulated and semi-regulated markets.
- Regulatory expertise in EU, UK, GCC, South Asia, Southeast Asia, and Africa markets with knowledge of country-specific parallel import frameworks.
- Full documentation support including certificates of origin, free sale certificates, manufacturer authorisation, and import permit management.
- GDP-compliant cold-chain and ambient logistics for all product categories, with validated packaging and real-time temperature monitoring.
- Transparent pricing with no hidden charges — clear quotation from enquiry to delivery.
- ISO 9001:2015 and WHO-GSDP certified operations ensuring quality and compliance at every stage of the supply chain.
Regulatory recognitions
Quality You Can Trust
Our internationally recognized certifications underscore our commitment to safety, quality, and excellence in pharmaceutical distribution.
